Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of weekly

[admin]

Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.